Page last updated: 2024-10-25

clonidine and Dermatitis Medicamentosa

clonidine has been researched along with Dermatitis Medicamentosa in 22 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research Excerpts

ExcerptRelevanceReference
"The efficacy and safety of two different galenic formulations of transdermal clonidine systems were compared in 905 patients with mild to moderate essential hypertension during a 12 weeks observation period."9.07Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension. ( Göbel, BO; Kolloch, RE; Mehlburger, L; Schumacher, H, 1993)
"The clonidine patch offers for the first time the unique possibility of a once-a-week transdermal therapy of hypertension due to direct absorption of clonidine through the skin."9.07One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. ( , 1993)
"The long-term safety and efficacy of transdermal clonidine (C-TTS) was evaluated in 102 patients with mild to moderate hypertension over a mean treatment period of 4."9.07Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. ( Breidthardt, J; Mehlburger, L; Schumacher, H, 1993)
"We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension."9.06Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989)
"The efficacy and safety of two different galenic formulations of transdermal clonidine systems were compared in 905 patients with mild to moderate essential hypertension during a 12 weeks observation period."5.07Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension. ( Göbel, BO; Kolloch, RE; Mehlburger, L; Schumacher, H, 1993)
"The clonidine patch offers for the first time the unique possibility of a once-a-week transdermal therapy of hypertension due to direct absorption of clonidine through the skin."5.07One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. ( , 1993)
"The long-term safety and efficacy of transdermal clonidine (C-TTS) was evaluated in 102 patients with mild to moderate hypertension over a mean treatment period of 4."5.07Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. ( Breidthardt, J; Mehlburger, L; Schumacher, H, 1993)
"We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension."5.06Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989)
"Transdermal clonidine was approved by the US Food and Drug Administration in 1984 for the treatment of mild-to-moderate hypertension alone or in combination with a diuretic."3.73Transdermal clonidine: therapeutic considerations. ( Grubbs, R; Sica, DA, 2005)
" Methods also have been developed to determine the skin irritation potential of a drug substance during the preclinical stages of transdermal dosage form development."2.66Testing of controlled-release transdermal dosage forms. Product development and clinical trials. ( Amkraut, AA; Prevo, ME; Shaw, JE, 1987)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-199011 (50.00)18.7374
1990's8 (36.36)18.2507
2000's3 (13.64)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haas, N1
Martens, F1
Henz, BM1
Sica, DA1
Grubbs, R1
Sills, M1
Congdon, P1
Forsythe, I1
van Joost, T1
Faber, WR1
Manuel, HR1
Kolloch, RE1
Mehlburger, L2
Schumacher, H2
Göbel, BO1
Breidthardt, J1
Weber, MA2
Kalish, R1
Wood, JA1
Wille, JJ1
Kydonieus, A1
Polster, AM1
Warner, MR1
Camisa, C1
Britt, MT1
Burnstine, MA1
Ito, MK1
O'Connor, DT1
Davies, SF1
Graif, JL1
Husebye, DG1
Maddy, MM1
McArthur, CD1
Path, MJ1
O'Connell, MB1
Iber, C1
Davidman, M1
Dick, JB1
Northridge, DB1
Lawson, AA1
Hollifield, J1
Shaw, JE1
Prevo, ME1
Amkraut, AA1
Kellaway, GS1
Lubbe, WF1
Groth, H1
Greminger, P1
Vetter, H1
Knüsel, J1
Baumgart, P1
Siegenthaler, W1
Vetter, W1
Grattan, CE1
Kennedy, CT1
Almeyda, J1
Levantine, A1

Reviews

1 review available for clonidine and Dermatitis Medicamentosa

ArticleYear
Cutaneous reactions to cardiovascular drugs.
    The British journal of dermatology, 1973, Volume: 88, Issue:3

    Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides;

1973

Trials

10 trials available for clonidine and Dermatitis Medicamentosa

ArticleYear
Clonidine and childhood migraine: a pilot and double-blind study.
    Developmental medicine and child neurology, 1982, Volume: 24, Issue:6

    Topics: Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Eruptions; F

1982
Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1993, Volume: 3, Issue:6

    Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Clonidine; Dose-Response Relationship, Drug;

1993
One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1993, Volume: 3, Issue:6

    Topics: Administration, Cutaneous; Adult; Blood Pressure; Clonidine; Drug Eruptions; Female; Heart Rate; Hum

1993
Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1993, Volume: 3, Issue:6

    Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Clonidine; Dose-Response Relationship, Drug;

1993
Skin pretreatment and the use of transdermal clonidine.
    The American journal of medicine, 1991, Jul-18, Volume: 91, Issue:1A

    Topics: Administration, Cutaneous; Administration, Topical; Adult; Aged; Aluminum Hydroxide; Antacids; Cloni

1991
Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Archives of internal medicine, 1989, Volume: 149, Issue:7

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Atenolol; Clonidine; Dermatitis, Contact; Do

1989
Skin reactions to long-term transdermal clonidine.
    Lancet (London, England), 1987, Feb-28, Volume: 1, Issue:8531

    Topics: Administration, Cutaneous; Clinical Trials as Topic; Clonidine; Drug Eruptions; Humans; Hypertension

1987
Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    American heart journal, 1986, Volume: 112, Issue:4

    Topics: Administration, Cutaneous; Blood Pressure; Clinical Trials as Topic; Clonidine; Drug Eruptions; Fema

1986
Transdermal antihypertensive therapy: clinical and metabolic considerations.
    American heart journal, 1986, Volume: 112, Issue:4

    Topics: Administration, Cutaneous; Blood Pressure; Clinical Trials as Topic; Clonidine; Drug Eruptions; Huma

1986
Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
    Archives of dermatology, 1987, Volume: 123, Issue:11

    Topics: Administration, Cutaneous; Animals; Biological Availability; Clinical Trials as Topic; Clonidine; De

1987

Other Studies

11 other studies available for clonidine and Dermatitis Medicamentosa

ArticleYear
Miliaria crystallina in an intensive care setting.
    Clinical and experimental dermatology, 2004, Volume: 29, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Clonidine; Critical Care; Dru

2004
Transdermal clonidine: therapeutic considerations.
    Journal of clinical hypertension (Greenwich, Conn.), 2005, Volume: 7, Issue:9

    Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Humans; Hypertension

2005
Drug-induced anogenital cicatricial pemphigoid.
    The British journal of dermatology, 1980, Volume: 102, Issue:6

    Topics: Anus Diseases; Clonidine; Drug Eruptions; Female; Humans; Middle Aged; Skin Diseases, Vesiculobullou

1980
The sympathetic nervous system and hypertension: mechanisms and treatment.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1993, Volume: 3, Issue:6

    Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Humans; Hypertension; Sympathetic Nervous Syst

1993
Sensitization of mice to topically applied drugs: albuterol, chlorpheniramine, clonidine and nadolol.
    Contact dermatitis, 1996, Volume: 35, Issue:2

    Topics: Administration, Cutaneous; Albuterol; Animals; Anti-Asthmatic Agents; Antihypertensive Agents; Biolo

1996
Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Cutis, 1999, Volume: 63, Issue:3

    Topics: Administration, Cutaneous; Aged; Antihypertensive Agents; Clonidine; Dermatitis, Allergic Contact; D

1999
Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion.
    The British journal of ophthalmology, 1999, Volume: 83, Issue:8

    Topics: Adrenergic alpha-Agonists; Cicatrix; Clonidine; Drug Eruptions; Ectropion; Entropion; Humans; Male;

1999
Cutaneous drug reaction case reports: from the world literature.
    American journal of clinical dermatology, 2002, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capecitabine; Carbamates; Ceftriaxone; Clonidine; Deoxyc

2002
Catapres-TTS: a two year posttrial followup.
    The New Zealand medical journal, 1988, Jun-08, Volume: 101, Issue:847 Pt 1

    Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Evaluation Studies as Topic; Follow-Up Studies

1988
[Transdermal clonidine: a new therapeutic approach in essential hypertension?].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1985, Mar-12, Volume: 74, Issue:11

    Topics: Administration, Topical; Adult; Aged; Blood Pressure; Clonidine; Drug Eruptions; Drug Therapy, Combi

1985
Allergic contact dermatitis to transdermal clonidine.
    Contact dermatitis, 1985, Volume: 12, Issue:4

    Topics: Administration, Topical; Clonidine; Drug Eruptions; Humans; Male; Middle Aged

1985